Jonatan Martinez-Gardeazabal, PhD
Affiliations: | 2021- | Pharmacology | University of the Basque Country UPV/EHU |
Google:
"Jonatan Martinez-Gardeazabal"Mean distance: (not calculated yet)
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Pereira-Castelo G, de Tena IB, Martínez-Gardeazabal J, et al. (2024) Neurolipid systems: A new target for the treatment of dementia. Basic & Clinical Pharmacology & Toxicology |
| Moreno-Rodriguez M, Perez SE, Martinez-Gardeazabal J, et al. (2024) Frontal Cortex Lipid Alterations During the Onset of Alzheimer's Disease. Journal of Alzheimer's Disease : Jad |
| Martínez-Gardeazabal J, Moreno-Rodríguez M, de San Román EG, et al. (2022) Mass Spectrometry for the Advancement of Lipid Analysis in Alzheimer's Research. Methods in Molecular Biology (Clifton, N.J.). 2561: 245-259 |
| Llorente-Ovejero A, Bengoetxea de Tena I, Martínez-Gardeazabal J, et al. (2022) Cannabinoid Receptors and Glial Response Following a Basal Forebrain Cholinergic Lesion. Acs Pharmacology & Translational Science. 5: 791-802 |
| Bengoetxea de Tena I, Moreno-Rodríguez M, Llorente-Ovejero A, et al. (2022) Handling and novel object recognition modulate fear response and endocannabinoid signaling in nucleus basalis magnocellularis. The European Journal of Neuroscience. 55: 1532-1546 |
| González de San Román E, Llorente-Ovejero A, Martínez-Gardeazabal J, et al. (2021) Modulation of Neurolipid Signaling and Specific Lipid Species in the Triple Transgenic Mouse Model of Alzheimer's Disease. International Journal of Molecular Sciences. 22 |
| Llorente-Ovejero A, Martínez-Gardeazabal J, Moreno-Rodríguez M, et al. (2021) Specific Phospholipid Modulation by Muscarinic Signaling in a Rat Lesion Model of Alzheimer's Disease. Acs Chemical Neuroscience |